Specific stabilization of CFTR by phosphatidylserine

Ellen Hildebrandt, Netaly Khazanov, John C. Kappes, Qun Dai, Hanoch Senderowitz, Ina L. Urbatsch

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR, ABCC7) is a plasma membrane chloride ion channel in the ABC transporter superfamily. CFTR is a key target for cystic fibrosis drug development, and its structural elucidation would advance those efforts. However, the limited in vivo and in vitro stability of the protein, particularly its nucleotide binding domains, has made structural studies challenging. Here we demonstrate that phosphatidylserine uniquely stimulates and thermally stabilizes the ATP hydrolysis function of purified human CFTR. Among several lipids tested, the greatest stabilization was observed with brain phosphatidylserine, which shifted the Tm for ATPase activity from 22.7 ± 0.8 °C to 35.0 ± 0.2 °C in wild-type CFTR, and from 26.6 ± 0.7 °C to 42.1 ± 0.2 °C in a more stable mutant CFTR having deleted regulatory insertion and S492P/A534P/I539T mutations. When ATPase activity was measured at 37 °C in the presence of brain phosphatidylserine, Vmax for wild-type CFTR was 240 ± 60 nmol/min/mg, a rate higher than previously reported and consistent with rates for other purified ABC transporters. The significant thermal stabilization of CFTR by phosphatidylserine may be advantageous in future structural and biophysical studies of CFTR.

Original languageEnglish
Pages (from-to)289-293
Number of pages5
JournalBiochimica et Biophysica Acta - Biomembranes
Volume1859
Issue number2
DOIs
StatePublished - 1 Feb 2017

Bibliographical note

Publisher Copyright:
© 2016

Funding

We thank Michael Blanton for guidance at the outset of the project, and Qinghai Zhang for his helpful critique of the manuscript. DNA comprising ∆RI/2PT CFTR was generously provided by John R. Riordan. This work was supported by Cystic Fibrosis Foundation Therapeutics grants URBATS13XX0 , SENDER13XX0 and DELUCA03G0 , by the National Institutes of Health including R01GM095639 , by the Virology, Genetic Sequencing and Flow Cytometry Cores of the UAB Center for AIDS Research ( P30 AI27767 ), and by The CH Foundation .

FundersFunder number
UAB Center for AIDS ResearchP30 AI27767
National Institutes of HealthR01GM095639
National Institute of Allergy and Infectious DiseasesP30AI027767
CH Foundation
Cystic Fibrosis Foundation TherapeuticsSENDER13XX0, DELUCA03G0, URBATS13XX0

    Keywords

    • ABC transporters
    • ATP hydrolysis
    • Blind docking
    • Cystic Fibrosis Transmembrane Conductance Regulator
    • Phosphatidylserine
    • Thermal stability

    Fingerprint

    Dive into the research topics of 'Specific stabilization of CFTR by phosphatidylserine'. Together they form a unique fingerprint.

    Cite this